Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tiwari (Birmingham, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), V. Titmuss (Portsmouth, United Kingdom), S. Babu (Portsmouth, United Kingdom). Characterisation of patients with chronic hypersensitivity pneumonitis (CHP) - a seven year single centre experience. 3003

Member's Comments

No comment yet.

Related content which might interest you: The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials Source: International Congress 2017 – Asthma management Year: 2017 Chronic eosinophilic pneumonia (CEP), our experience on 25 cases in a 10 year period Source: Eur Respir J 2006; 28: Suppl. 50, 381s Year: 2006 Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Acute exacerbations of interstitial lung diseases:experience of 6 years from a portuguese hospital center Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Safety of Mepolizumab for severe eosinophilic refractory asthma in a single-center cohort including a patient with echinococcus hepatic cyst and a patient with lung cancer . A single center one year follow up. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Does omalizumab attenuate blood eosinophilia at 52 weeks; a single centre observation Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Clinical course in hypersensitivity pneumonitis: a review of 38 cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs) Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008 Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Occurrence of hypersensitivity to beryllium among patients with diagnosed sarcoidosis. Initial results Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Pathogenisis of hypersensitivity pneumonitis (HP) - current concepts  Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management Year: 2017 Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Evaluation of Behcet‘s disease patients who admitted with pulmonary symptoms (analysis of 14 cases) Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Effect of genotype on hypersensitivity pneumonitis despite treatment. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP) Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006